Form 4 for NVAX NOVAVAX INC
Accepted 2026-01-26 00:00:00 ET · period of report 2026-01-23 · accession 0001104659-26-006721 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-26 | 2026-01-23 | NVAX | Jacobs John C | Pres, CEO, Dir | F - Tax | $9.17 | -39.1K | 180.8K | -18% | -$358.8K |
| D | 2026-01-26 | 2026-01-23 | NVAX | Jacobs John C | Pres, CEO, Dir | M - OptEx | $0.00 | +83.2K | 219.9K | +61% | $0 |
| D | 2026-01-26 | 2026-01-23 | NVAX | Jacobs John C | Pres, CEO, Dir | M - OptEx | $0.00 | -83.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-23 | F | D | 39,132 | $9.17 | 180,797 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-23 | M | A | 83,197 | $0.00 | 219,929 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-01-23 | M | D | 83,197 | $0.00 | 0 | D | $0.00 · — to 2033-03-03 | 83,197 Common Stock | (F1) One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date. |